
Sign up to save your podcasts
Or


Audio roundup of selected biopharma industry content from Scrip over the business week ended July 10, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time–Vertex's Crinetics deal; AstraZeneca's Phase III fail; J&J's deal focus; Ipsen's search for diamonds; and Dyne's CEO on strategy.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-RR3G5D6X5NEANCNJ2DVQ7OCAS4/
A quick update for our listeners: Scrip now has its own dedicated podcast channel on Spotify and Apple Podcasts. Be sure to subscribe to get all episodes.
By NorstellaAudio roundup of selected biopharma industry content from Scrip over the business week ended July 10, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time–Vertex's Crinetics deal; AstraZeneca's Phase III fail; J&J's deal focus; Ipsen's search for diamonds; and Dyne's CEO on strategy.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-RR3G5D6X5NEANCNJ2DVQ7OCAS4/
A quick update for our listeners: Scrip now has its own dedicated podcast channel on Spotify and Apple Podcasts. Be sure to subscribe to get all episodes.